Get startedLog in
    Picture of ORYZON Genomics SA logo

    ORY — ORYZON Genomics SA News Story

    0.000.00%
    es flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    All News

    Brief: Oryzon Announces US Patent Grant Covering Iadademstat Combinations For AML

    Picture of ORYZON Genomics SA logoORYZON Genomics SA
    23/03/2026 06:36
    March 23 (Reuters) - Oryzon Genomics SA ORY.MC:

ANNOUNCES U.S. PATENT GRANT COVERING IADADEMSTAT COMBINATIONS WITH VENETOCLAX

KEY COMBINATION FOR THE TREATMENT OF FIRST-LINE ACUTE MYELOID LEUKEMIA (AML)

PATENT EXPECTED TO EXPIRE IN JAN 2039

Source text: https://tinyurl.com/yb5rkhfj

Further company coverage: ORY.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on ORYZON Genomics SA

    See all news